Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Conditions
Keywords
relationship, endothelial injury, vascular permeability, severe sepsis related ALI/ARDS
Brief summary
To investigate the possible mechanisms of pulmonary and systemic permeability change including cytokine, extravascular lung water index (EVLWI), and oxygenation parameters in patients with sepsis related acute lung injury (ALI)/acute respiratory distress syndrome (ARDS).
Detailed description
This investigation is a prospective control study. Informed consents will be obtained from all patients or their surrogates prior to the procedure of EVLWI measurement and blood sampling for molecular measurement including cytokines. From July 2011 to June 2014, consecutive septic patients with ARDS in intensive care units (ICUs) will be enrolled at Chang Gung Memorial Hospital, a university-affiliated hospital in Taiwan. EVLWI will be measured by PiCCO monitoring system. Serum cytokine such as endothelin-1, TNF-alfa, IL-6, Tie-1, Tie-2, angiopoietin-1, angiopoietin-2,VEGF and thrombomodulin will be measured.
Interventions
The EVLW measurement will be based on transpulmonary thermodilution method. This method was recently introduced as part of the PiCCO plus system (Pulsion Medical System, Munich, Germany), for monitoring severe sepsis patients being treated in medical ICUs. This method only used a single indicator (cold saline solution), and demonstrated a satisfactory correlation with the gravimetric method. A 4-F arterial catheter (PulsiocathPV2014L16; Pulsion Medical Systems, Munich, Germany) was positioned in the descending aorta via the femoral artery using the Seldinger technique. The femoral arterial catheter and a standard central venous catheter were connected to pressure transducers, and also to an integrated bedside monitor (PiCCO; Pulsion Medical Systems).
Sponsors
Study design
Eligibility
Inclusion criteria
* sepsis in ICU within 48 hours, * mechanical ventilator use, * PaO2/FiO2 \< 300,
Exclusion criteria
* age younger than 20 years, * known pregnancy, * participation in another trial within 30 days before meeting the eligibility criteria, and * terminal malignancy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| vascular permeability of sepsis related ALI/ARDS | 3 days | vascular permeability (day 1 and 3 EVLWI, lung permeability, 24hr fluid balance, microalbuminuria, DAMPs/RAGE, Ang-1, 2 and TIE-2 level, will be detected in the blood sampling) and sepsis-induced ALI/ARDS. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| relationship between endothelial injury and vascular permeability. | 3 days | relationship between endothelial injury (serum TM, vWF, VEGF, TIE-2 increase and imbalance of ANG-1/ANG-2) and vascular permeability in patients with sepsis related ALI/ARDS. |
Countries
Taiwan